Skip to content
ADDRESS-2 type 1 diabetes

ADDRESS-2 type 1 diabetes

Supporting type 1 diabetes research

Menu

  • Home
  • How to take part
    • Map of Participating Sites
    • Privacy notices
  • Type 1 Diabetes Studies
    • Other ways to get involved
    • Past studies
  • Support for Researchers
    • Gaining access to ADDRESS-2
  • News & features
    • Newsletters
    • Publications
    • Study outcomes
    • Improving access to research
    • Helping researchers
    • T1DUK
  • About us
  • Contact Us

A potential vaccine for type 1 diabetes: the MultiPepT1De trial

The latest study we are supporting is investigating a potential vaccine for type 1 diabetes. Find out about the MultiPepTide trial from the team running the trial, and from Diabetes UK.

Read about other studies we are supporting.

multipept1de-logo

liu-vaccine

A potential vaccine for type 1 diabetes: the MultiPepT1De trial
Tagged on: News
address-2 January 8, 2016December 2, 2016 Research study
  • Trial of a new drug aiming to preserve beta cells →

Archives

  • July 2018
  • October 2017
  • August 2017
  • July 2017
  • March 2017
  • September 2016
  • January 2016

Share this content

Facebooktwitter

Follow Us

Facebooktwitter

Other Links

Privacy notices

Accessibility statement

Contact us

Email:
address2@imperial.ac.uk

Phone:
0207 594 1316
0207 594 5960

Postal address

Diabetes, Endocrinology and Metabolism
Imperial College London
G3, Medical School Building
Norfolk Place
London, W2 1PG

Copyright © 2021 ADDRESS-2 type 1 diabetes. All rights reserved. Theme Spacious by ThemeGrill. Powered by: WordPress.